Review
Jul 2026
Antibody-drug conjugates in colorectal cancer: advances, challenges, and prospectives.
Future research should prioritize tumor-selective linker design, novel payload development, bispecific and dual-payload ADC platforms, and rational combination strategies to overcome resistance and further improve the therapeutic index of ADCs in CRC.
L. Zeng, Yuanlin Zhu, Ke Zhang et al.
· Biochemical Pharmacology · 0 citations